Cannabis-based medicinal products (CBMPs) are prescribed with increased frequency, despite a paucity of high-quality randomized controlled trials. The aim of this study is to analyze the early outcomes of the first series of patients prescribed CBMPs in the UK with respect to effects on health-related quality of life and clinical safety.
The post An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients appeared first on Society of Cannabis Clinicians.